• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of April 3, 2013

  • Print
  • Share
  • E-mail

Product Detail

Product Description Red Blood Cells (Apheresis)
Recall Number B-0866-13
Classification Class II
Code Info W047008155090A; 047008155046A; W047008155046B; W047008155053A; W047008155053B; W047008155085A; W047008155085B; W047008155087A; W047008155087B; W047008155088A; W047008155089A; W047008155091B; W047008155093A; W047008155093B; W047008155094A; W047008155094B; W047008155118B; W047008155120B; W047008155121B; W047008155122B; W047008155118A; W047008155120A; W047008155121A; W047008155122A; W047008155123A; W047008155123B; W047008155124B; W047008155125B; W047008161334B; W047008161341B; W047008184441B; W047008184422B; W047008184435B; W047008184441B; W047008155124A; W047008155125A; W047008161334A; W047008161341A; W047008184441A; W047008184422A; W047008184435A; W047008184441A
Product Distributed Qty 42 units
Reason For Recall Blood products, which did not meet the acceptable product specifications, were distributed.

Event Detail

Event Id 52254
Product Type Biologics
Status Terminated
Recalling Firm New York Blood Center, Inc.
City New York
State NY
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2009-03-09
Initial Firm Notification of Consignee or Public Letter
Distribution Pattern NY